Severe COVID while pregnant - none had taken any vitamin D
Impact of vitamin D on the course of COVID-19 during pregnancy: A case control study
J Steroid Biochem Mol Biol . 2021 Oct;213:105964. doi: 10.1016/j.jsbmb.2021.105964
Selcan Sinaci 1, Doga Fatma Ocal 2, Didem Fatma Yucel Yetiskin 2, Derya Uyan Hendem 2, Gul Nihal Buyuk 2, Sule Goncu Ayhan 2, Atakan Tanacan 2, A Seval Ozgu-Erdinc 2, Ozlem Moraloglu Tekin 3, Dilek Sahin 3
Affiliations expand
Objective: We aimed to evaluate the vitamin D status of pregnant women with COVID-19, and the association between vitamin D level and severity of COVID-19.
Methods: In this case control study, 159 women with a single pregnancy and tested positive for SARS-CoV-2, and randomly selected 332 healthy pregnant women with similar gestational ages were included. COVID-19 patients were classified as mild, moderate, and severe. Vitamin D deficiency was defined as 25-hydroxycholecalciferol <20 ng/mL (50 nmol/L), and 25-OH D vitamin <10 ng/mL was defined as severe vitamin D deficiency, also 25-OH D vitamin level between 20-29 ng/mL (525-725 nmol/L) was defined as vitamin D insufficiency.
Results: Vitamin D levels of the pregnant women in the COVID-19 group (12.46) were lower than the control group (18.76). 25-OH D vitamin levels of those in the mild COVID-19 category (13.69) were significantly higher than those in the moderate/severe category (9.06). In terms of taking vitamin D supplementation, there was no statistically significant difference between the groups. However, it was observed that all of those who had severe COVID-19 were the patients who did not take vitamin D supplementation.
Conclusion: The vitamin D levels are low in pregnant women with COVID-19. Also, there is a significant difference regarding to vitamin D level and COVID-19 severity in pregnant women. Maintenance of adequate vitamin D level can be useful as an approach for the prevention of an aggressive course of the inflammation induced by this novel coronavirus in pregnant women.
📄 Download the PDF from VitaminDWiki
Clipped from PDF
There was no statistically significant relationship between vitamin D supplementation and COVID-19 severity (p > 0.05). However, it was observed that all of those who had severe COVID-19 were the patients who did not take vitamin D supplementation .
In those taking vitamin D supplementation, the mild COVID-19 rate was 77.8 %; while moderate and severe was 22.2 %, as seen in Table 6.
VitaminDWiki – studies in both categories Virus and Pregnancy
This list is automatically updated
{category}
VitaminDWiki – COVID-19 treated by Vitamin D - studies, reports, videos
{include}
see also some Virus interventions and meta-analyses in VitaminDWiki
Interventions
4X less likely to get COVID following 4,000 IU daily for a month – RCT April 2022
Group achieving 30 ng (vs 26 ng) were 2X less likely to get COVID symptoms - RCT Jan 2022
-
Meta-analyses
COVID test positive is about half as likely if have Vitamin D – 24th meta-analysis - Jan 2022
Vitamin D fights COVID (54 studies of 1,400,000 people) – 23rd meta-analysis - Dec 2021
COVID-19 treated by Vitamin D (reduce ICU by 3X) - 22nd meta-analysis - Dec 29, 2021
VitaminDWiki - Pregnancy category
{include}